Skip to content

Epidemiological study of nonsurgical intervention and disease outcome for large joint articular cartilage defects

Epidemiological study of nonsurgical intervention and disease outcome for large joint articular cartilage defects

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035799
Enrollment
Unknown
Registered
2020-08-17
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Large joint articular cartilage defect

Interventions

Case series:non repair surgery

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Aged 16-55 years old, cartilage defect on hip, knee and ankle, male or female; 2. Full-thickness large cartilage defect (1-20 cm2, International Cartilage Repair Society [ICRS] grade III-IV); 3. Patients diagnosed as cartilage defect during January 2019 to June 2022; 4. Unwilling for surgical treatment or have missed the optimal surgery timing; 5. Agree to take part into this clinical trial and signed the informed consent approved by the Ethic Committee.

Exclusion criteria

Exclusion criteria: 1. Systemic or inflammatory arthritis (e.g. rheumatoid arthritis), gout, a history of neuro-arthritis and other muscle, joint, or nervous system diseases that affect lower limb function; 2. Patient with immunosuppression or acute infection 3. Obese, BMI>30 4. Patient unable to communicate normally or having a history of mental, psychological or neurological diseases which seriously affect investigation and evaluation 5. Joint malformation or severe dysplasia 6. Unable to determine the time of diagnosis; critical joint imaging data is incomplete; 7. Unable to cooperate with MRI, CT or X-ray examinations at critical time points within 2 years after diagnosis

Design outcomes

Primary

MeasureTime frame
arthritis prevalence within two years;

Secondary

MeasureTime frame
arthritis prevalence within one year;Joint function score within 1-2years;Joint pain VAS score;EQ-5D-3L score;

Countries

China

Contacts

Public ContactChangqing Zhang

Shanghai Sixth People's Hospital

zhangcq@sjtu.edu.cn+86 21 24058009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026